Brammer Bio Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
600
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
2
Brammer Bio General Information
Description
Manufacturer of viral vector for gene and cell therapies, intended to improve patients' health. The company provides clinical and commercial development, manufacturing supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with the process and analytical development, and regulatory support, enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies.
Contact Information
Website
www.brammerbio.comCorporate Office
- 250 Binney Street
- Cambridge, MA 02142
- United States
Corporate Office
- 250 Binney Street
- Cambridge, MA 02142
- United States
Brammer Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Brammer Bio Comparisons
Industry
Financing
Details
Brammer Bio Competitors (42)
One of Brammer Bio’s 42 competitors is Batavia Biosciences, a Corporate Backed or Acquired company based in Leiden, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Batavia Biosciences | Corporate Backed or Acquired | Leiden, Netherlands | ||||
| TCG Lifesciences | Corporation | Kolkata, India | ||||
| Vector Biolabs | Corporation | PA | ||||
| IDT Biologika | Corporate Backed or Acquired | Dessau-Rosslau, Germany | ||||
| CordenPharma | Private Equity-Backed | Basel, Switzerland |
Brammer Bio Patents
Brammer Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026148287-A1 | Residual cell penetrating peptide detection by lc-ms | Pending | 06-Jan-2025 | ||
| WO-2026096784-A1 | Characterization of beads in cell samples | Pending | 31-Oct-2024 | ||
| EP-4758424-A1 | Detection of variability in viruses | Pending | 08-Aug-2023 | ||
| WO-2025035009-A1 | Detection of variability in viruses | Inactive | 08-Aug-2023 | ||
| EP-4425446-A1 | Supervised machine learning based classification of adeno associated viruses in cryogenic electron microscopy (cryo-em) | Pending | 01-Mar-2023 | G06V20/698 |
Brammer Bio Signals
Brammer Bio Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Brammer Bio Investments (2)
Brammer Bio’s most recent deal was a Buyout/LBO with Biogen (49,000-sq.-ft. Warehouse in Somerville, Massachusetts). The deal was made on 01-Jan-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biogen (49,000-sq.-ft. Warehouse in Somerville, Massachusetts) | 01-Jan-2017 | Buyout/LBO | Buildings and Property | ||
| Brammer Biopharmaceuticals | 31-Mar-2016 | Buyout/LBO | Other Pharmaceuticals and Biotechnology |
Brammer Bio FAQs
-
When was Brammer Bio founded?
Brammer Bio was founded in 2006.
-
Where is Brammer Bio headquartered?
Brammer Bio is headquartered in Cambridge, MA.
-
What is the size of Brammer Bio?
Brammer Bio has 600 total employees.
-
What industry is Brammer Bio in?
Brammer Bio’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Brammer Bio a private or public company?
Brammer Bio is a Private company.
-
What is the current valuation of Brammer Bio?
The current valuation of Brammer Bio is .
-
What is Brammer Bio’s current revenue?
The current revenue for Brammer Bio is .
-
Who are Brammer Bio’s investors?
Ampersand Capital Partners and University of Florida Investment Corporation have invested in Brammer Bio.
-
Who are Brammer Bio’s competitors?
Batavia Biosciences, TCG Lifesciences, Vector Biolabs, IDT Biologika, and CordenPharma are some of the 42 competitors of Brammer Bio.
-
When was Brammer Bio acquired?
Brammer Bio was acquired on 30-Apr-2019.
-
Who acquired Brammer Bio?
Brammer Bio was acquired by Thermo Fisher Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process